AVR 1.04% $11.43 anteris technologies ltd

Ann: Admedus HSV-2 Phase II Study Interim Update, page-7

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 351 Posts.
    lightbulb Created with Sketch. 1
    You little ripper. Gotta agree about increasing the size of the stake in Admedus Vaccines -its a good sign.
    Have to temper the announcement with the knowledge that a vaccine is 6 to 10 years away. But its a good announcement and cheered me up as I lost big when I hit stop/losses on Monday.
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
(20min delay)
Last
$11.43
Change
-0.120(1.04%)
Mkt cap ! $241.6M
Open High Low Value Volume
$11.58 $11.58 $11.17 $196.0K 17.23K

Buyers (Bids)

No. Vol. Price($)
1 30 $11.40
 

Sellers (Offers)

Price($) Vol. No.
$11.50 200 1
View Market Depth
Last trade - 16.10pm 14/10/2024 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.